feed,title,long_url,short_url
Benzinga,"FDA Approves Bristol-Myers' Opdualag, First LAG-3-Blocking Antibody Combo, For Melanoma Patients",https://benzinga.com/general/biotech/22/03/26214713/fda-approves-bristol-myers-opdualag-first-lag-3-blocking-antibody-combo-for-melanoma-patients,https://bit.ly/3CVOttE
